Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
J Am Acad Dermatol. 2018 Feb;78(2):310-314.e1. doi: 10.1016/j.jaad.2017.09.040. Epub 2017 Sep 22.
The risk of postoperative pyoderma gangrenosum (PG) in patients with a known history of PG is unknown.
To quantify risk and identify patient- and/or procedure-related risk factors for postsurgical recurrence or exacerbation of PG in patients with a known history of PG.
We retrospectively evaluated the likelihood of postsurgical recurrence or exacerbation of PG for all patients with a confirmed diagnosis of PG at Brigham and Women's Hospital and Massachusetts General Hospital from 2000 to 2015.
In all, 5.5% of procedures (n = 33) led to recurrence of PG in 15.1% of patients (n = 25). Compared with skin biopsy, small open surgical procedures had an adjusted odds ratio (aOR) of 8.65 (95% confidence interval [CI], 1.55-48.33) for PG recurrence or exacerbation; large open surgical procedures had an aOR of 5.97 (95% CI, 1.70-21.00); and Mohs micrographic surgery/skin excision had an aOR of 6.47 (95% CI, 1.77-23.61). PG chronically present at the time of the procedure had an aOR of 4.58 (95% CI, 1.72-12.22). Immunosuppression, time elapsed since the original PG diagnosis, and procedure location did not significantly influence risk.
Our study is limited by its retrospective nature and relatively small sample size.
There is a small but clinically meaningful risk for postsurgical recurrence or exacerbation of PG in patients with a known history of PG; higher risks occur with more invasive procedures and chronically present PG.
已知患有坏疽性脓皮病(PG)病史的患者术后发生 PG 的风险未知。
量化风险,并确定患有已知 PG 病史的患者术后 PG 复发或恶化的与患者和/或手术相关的危险因素。
我们回顾性评估了 2000 年至 2015 年期间在布莱根妇女医院和马萨诸塞州综合医院确诊患有 PG 的所有患者发生术后 PG 复发或恶化的可能性。
所有手术中有 5.5%(n=33)导致 15.1%(n=25)的患者 PG 复发。与皮肤活检相比,小的开放性手术 PG 复发或恶化的调整比值比(aOR)为 8.65(95%置信区间[CI],1.55-48.33);大的开放性手术为 5.97(95%CI,1.70-21.00);Mohs 显微外科/皮肤切除术为 6.47(95%CI,1.77-23.61)。手术时 PG 持续存在的患者 aOR 为 4.58(95%CI,1.72-12.22)。免疫抑制、PG 确诊后时间间隔以及手术部位并未显著影响风险。
本研究受限于回顾性设计和相对较小的样本量。
已知患有 PG 病史的患者术后 PG 复发或恶化的风险虽小,但具有临床意义;更具侵袭性的手术和慢性 PG 会增加风险。